doi: 10.3389/fimmu.2025.1558414 Received 13 January 2025 Accepted 04 February 2025 Published 21 February 2025 Volume 16 - 2025 Edited by Jin-Yi Wan, Beijing University of Chinese Medicine, China Reviewed by Hui Ye, Peking University, China Ke Xiao, Shandong University, China Weihan Zhao, Shaanxi University of Chinese Medicine, China Updates Copyright 2025 Guan, Cheng, Zhang, Cai, Zhang, Jiang, Wang, Zeng and Jia
The FDA has approved intravenous (by IV) L-carnitine for treating and preventing L-carnitine deficiency in these patients
Bypassing the digestive system allows nutrients to enter your bloodstream immediately, maximizing absorption to 99.9%
At this stage in the deficiency all four chambers of the heart enlarge due to loss of energy generation and fluid retention resulting in what is called dilated cardiomyopathy